PMC Links for Books (Select 5247994) - PMC

Select item 96065231.

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Désirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song

Ann Rheum Dis. 2022 Nov; 81(11): 1515–1523. Published online 2022 Jul 4. doi: 10.1136/ard-2022-222608

PMCID:: PMC9606523

Abstract Article PDF–916K

Select item 87871892.

Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews

Yun-Kyoung Song, Junu Song, Kyungim Kim, Jin-Won Kwon

Front Pharmacol. 2021; 12: 792877. Published online 2022 Jan 11. doi: 10.3389/fphar.2021.792877

PMCID:: PMC8787189

Abstract Article PDF–818K

Select item 87178273.

Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials

Gerd R. Burmester, Kevin Winthrop, Ricardo Blanco, Peter Nash, Philippe Goupille, Valderilio F. Azevedo, Carlo Salvarani, Andrea Rubbert-Roth, Elizabeth Lesser, Ralph Lippe, Apinya Lertratanakul, Reva M. Mccaskill, John Liu, Eric M. Ruderman

Rheumatol Ther. 2022 Apr; 9(2): 521–539. Published online 2021 Dec 30. doi: 10.1007/s40744-021-00410-z

PMCID:: PMC8717827

Abstract Article PDF–917K

Select item 83400154.

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson, Antonio Costanzo, Marjolein De Bruin-Weller, Sebastien Barbarot, Vimal H. Prajapati, Peter Lio, Xiaofei Hu, Tianshuang Wu, John Liu, Barry Ladizinski, Alvina D. Chu, Kilian Eyerich

JAMA Dermatol. 2021 Sep; 157(9): 1047–1055. Published online 2021 Aug 4. doi: 10.1001/jamadermatol.2021.3023

Correction in:: JAMA Dermatol. 2022 Feb; 158(2): 219.

Correction in:: JAMA Dermatol. 2024 Mar; 160(3): 370.

PMCID:: PMC8340015

Abstract Article

Select item 82174175.

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study

Philip J. Mease, Apinya Lertratanakul, Kim A. Papp, Filip E. van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro W. Keiserman, Xianwei Bu, Liang Chen, Reva M. McCaskill, Patrick Zueger, Erin L. McDearmon-Blondell, Aileen L. Pangan, William Tillett

Rheumatol Ther. 2021 Jun; 8(2): 903–919. Published online 2021 Apr 28. doi: 10.1007/s40744-021-00305-z

PMCID:: PMC8217417

Abstract Article PDF–547K

Select item 80981046.

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis

Eduardo Mysler, Ana Lizarraga

Rheumatology (Oxford) 2021 May; 60(Suppl 2): ii17–ii23. Published online 2021 May 5. doi: 10.1093/rheumatology/keaa823

PMCID:: PMC8098104

Abstract Article PDF–83K

Select item 80981037.

The safety of JAK-1 inhibitors

Benjamin Clarke, Mark Yates, Maryam Adas, Katie Bechman, James Galloway

Rheumatology (Oxford) 2021 May; 60(Suppl 2): ii24–ii30. Published online 2021 May 5. doi: 10.1093/rheumatology/keaa895

PMCID:: PMC8098103

Abstract Article PDF–261K

Select item 78923828.

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

Stanley B Cohen, Ronald F van Vollenhoven, Kevin L Winthrop, Cristiano A F Zerbini, Yoshiya Tanaka, Louis Bessette, Ying Zhang, Nasser Khan, Barbara Hendrickson, Jeffrey V Enejosa, Gerd R Burmester

Ann Rheum Dis. 2021 Mar; 80(3): 304–311. Published online 2020 Oct 28. doi: 10.1136/annrheumdis-2020-218510

Correction in:: Ann Rheum Dis. 2021 May; 80(5): e83.

PMCID:: PMC7892382

Abstract Article PDF–651K

Select item 75893759.

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial

Ronald van Vollenhoven, Tsutomu Takeuchi, Aileen L. Pangan, Alan Friedman, Mohamed‐Eslam F. Mohamed, Su Chen, Maureen Rischmueller, Ricardo Blanco, Ricardo M. Xavier, Vibeke Strand

Arthritis Rheumatol. 2020 Oct; 72(10): 1607–1620. Published online 2020 Sep 8. doi: 10.1002/art.41384

PMCID:: PMC7589375

Abstract Article PDF–984K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 9

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity